Enema Device for Children With Spina Bifida
Launched by UNIVERSITY OF COLORADO, DENVER · Feb 14, 2022
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new enema device designed to help children with spina bifida who experience fecal incontinence, which means they have difficulty controlling their bowel movements. The trial aims to improve the way enemas are administered, making it easier and more effective for these children to manage their bowel health. Currently, many of these kids use a special program to stay clean, but those with spina bifida often have more challenges due to weaker muscle control around the anus. This study seeks to create a better tool to help them have fewer accidents and feel more confident.
To be eligible for this trial, participants should be between 2 and 30 years old, have poor muscle tone in the anal area, and regularly use enemas as part of their bowel management. Unfortunately, non-English speakers, pregnant women, and certain other individuals cannot participate. If eligible, participants can expect to help test this new device, which could lead to better bowel management options for kids with spina bifida and improve their quality of life.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Poor sphincter tone
- • Perform regular enemas for bowel management (due to fecal incontinence)
- • 2 - 30 years old
- Exclusion Criteria:
- • Non English speakers
- • Prisoners
- • Pregnant women
- • Wards of state
- • Decisionally challenged adults
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials